Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 公共衛生學院
  3. 流行病學與預防醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62949
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor季瑋珠(Wei-Chu Chie)
dc.contributor.authorYun-Chen Koen
dc.contributor.author柯澐蓁zh_TW
dc.date.accessioned2021-06-16T16:16:06Z-
dc.date.available2022-09-01
dc.date.copyright2020-09-01
dc.date.issued2020
dc.date.submitted2020-05-26
dc.identifier.citation1. Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127: 990S-991S.
2. Bischoff-Ferrari HA, Orav JE, Kanis JA, et al. Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older. Osteoporos Int. 2015;26: 2793-2802.
3. De Buyser SL, Petrovic M, Taes YE, et al. Validation of the FNIH sarcopenia criteria and SOF frailty index as predictors of long-term mortality in ambulatory older men. Age Ageing. 2016;45: 602-608.
4. Demling RH. Nutrition, anabolism, and the wound healing process: an overview. Eplasty. 2009;9: e9.
5. Vellas B, Fielding RA, Bens C, et al. Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2018;7: 2-9.
6. Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48: 48-56.
7. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147: 755-763.
8. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39: 412-423.
9. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48: 601.
10. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12: 249-256.
11. Chen LK, Liu LK, Woo J, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15: 95-101.
12. Chen LK, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21: 300-307 e302.
13. Leon AS. Attenuation of Adverse Effects of Aging on Skeletal Muscle by Regular Exercise and Nutritional Support. Am J Lifestyle Med. 2017;11: 4-16.
14. Beaudart C, Dawson A, Shaw SC, et al. Nutrition and physical activity in the prevention and treatment of sarcopenia: systematic review. Osteoporos Int. 2017;28: 1817-1833.
15. Mijnarends DM, Koster A, Schols JM, et al. Physical activity and incidence of sarcopenia: the population-based AGES-Reykjavik Study. Age Ageing. 2016;45: 614-620.
16. World health organization. Physical activity. https://www.who.int/health-topics/physical-activity Accessed Feb. 10, 2020.
17. Global health risks: mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization; 2009.
18. World Health Organization. Global recommendations on physical activity for health (65 years and above). https://www.who.int/dietphysicalactivity/physical-activity-recommendations-65years.pdf Accessed Feb. 10, 2020.
19. Dowd KP, Szeklicki R, Minetto MA, et al. A systematic literature review of reviews on techniques for physical activity measurement in adults: a DEDIPAC study. Int J Behav Nutr Phys Act. 2018;15: 15.
20. Steene-Johannessen J, Anderssen SA, van der Ploeg HP, et al. Are Self-report Measures Able to Define Individuals as Physically Active or Inactive? Med Sci Sports Exerc. 2016;48: 235-244.
21. Sylvia LG, Bernstein EE, Hubbard JL, Keating L, Anderson EJ. Practical guide to measuring physical activity. J Acad Nutr Diet. 2014;114: 199-208.
22. YM Liou, Development and Verification of Validity and Reliability of the International Physical. Activity Questionnaire Taiwan Version DOI: 10.6342/NTU.2004.02074
23. Liou YM, Jwo CJ, Yao KG, Chiang LC, Huang LH. Selection of appropriate Chinese terms to represent intensity and types of physical activity terms for use in the Taiwan version of IPAQ. J Nurs Res. 2008;16: 252-263.
24. Steffl M, Bohannon RW, Sontakova L, Tufano JJ, Shiells K, Holmerova I. Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis. Clin Interv Aging. 2017;12: 835-845.
25. Carlson ME, Suetta C, Conboy MJ, et al. Molecular aging and rejuvenation of human muscle stem cells. EMBO Mol Med. 2009;1: 381-391.
26. Volpi E, Nazemi R, Fujita S. Muscle tissue changes with aging. Curr Opin Clin Nutr Metab Care. 2004;7: 405-410.
27. Goodpaster BH, Park SW, Harris TB, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci. 2006;61: 1059-1064.
28. Linge J, Heymsfield SB, Dahlqvist Leinhard O. On the Definition of Sarcopenia in the Presence of Aging and Obesity-Initial Results from UK Biobank. J Gerontol A Biol Sci Med Sci. 2019.
29. Yu F, Hedstrom M, Cristea A, Dalen N, Larsson L. Effects of ageing and gender on contractile properties in human skeletal muscle and single fibres. Acta Physiol (Oxf). 2007;190: 229-241.
30. Ryu M, Jo J, Lee Y, Chung YS, Kim KM, Baek WC. Association of physical activity with sarcopenia and sarcopenic obesity in community-dwelling older adults: the Fourth Korea National Health and Nutrition Examination Survey. Age Ageing. 2013;42: 734-740.
31. Jeng C, Zhao LJ, Wu K, Zhou Y, Chen T, Deng HW. Race and socioeconomic effect on sarcopenia and sarcopenic obesity in the Louisiana Osteoporosis Study (LOS). JCSM Clin Rep. 2018;3.
32. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69: 438-446.
33. Tyrovolas S, Koyanagi A, Olaya B, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. J Cachexia Sarcopenia Muscle. 2016;7: 312-321.
34. Kim CR, Jeon YJ, Jeong T. Risk factors associated with low handgrip strength in the older Korean population. PLoS One. 2019;14: e0214612.
35. Trajanoska K, Schoufour JD, Darweesh SK, et al. Sarcopenia and Its Clinical Correlates in the General Population: The Rotterdam Study. J Bone Miner Res. 2018;33: 1209-1218.
36. Moreira VG, Perez M, Lourenco RA. Prevalence of sarcopenia and its associated factors: the impact of muscle mass, gait speed, and handgrip strength reference values on reported frequencies. Clinics (Sao Paulo). 2019;74: e477.
37. Schalk BW, Deeg DJ, Penninx BW, Bouter LM, Visser M. Serum albumin and muscle strength: a longitudinal study in older men and women. J Am Geriatr Soc. 2005;53: 1331-1338.
38. Lee SW, Youm Y, Lee WJ, et al. Appendicular skeletal muscle mass and insulin resistance in an elderly korean population: the korean social life, health and aging project-health examination cohort. Diabetes Metab J. 2015;39: 37-45.
39. Zhang Z, Pereira SL, Luo M, Matheson EM. Evaluation of Blood Biomarkers Associated with Risk of Malnutrition in Older Adults: A Systematic Review and Meta-Analysis. Nutrients. 2017;9.
40. Chung TH, Kwon YJ, Shim JY, Lee YJ. Association between serum triglyceride to high-density lipoprotein cholesterol ratio and sarcopenia in elderly Korean males: The Korean National Health and Nutrition Examination Survey. Clin Chim Acta. 2016;463: 165-168.
41. Lu Y, Karagounis LG, Ng TP, et al. Systemic and Metabolic Signature of Sarcopenia in Community-Dwelling Older Adults. J Gerontol A Biol Sci Med Sci. 2020;75: 309-317.
42. Goodpaster BH, Brown NF. Skeletal muscle lipid and its association with insulin resistance: what is the role for exercise? Exerc Sport Sci Rev. 2005;33: 150-154.
43. Du Y, Oh C, No J. Associations between Sarcopenia and Metabolic Risk Factors: A Systematic Review and Meta-Analysis. J Obes Metab Syndr. 2018;27: 175-185.
44. Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104: 2263-2268.
45. Cesari M, Penninx BW, Lauretani F, et al. Hemoglobin levels and skeletal muscle: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2004;59: 249-254.
46. Hirani V, Naganathan V, Blyth F, et al. Low Hemoglobin Concentrations Are Associated With Sarcopenia, Physical Performance, and Disability in Older Australian Men in Cross-sectional and Longitudinal Analysis: The Concord Health and Ageing in Men Project. J Gerontol A Biol Sci Med Sci. 2016;71: 1667-1675.
47. Molino-Lova R, Sofi F, Pasquini G, et al. Higher uric acid serum levels are associated with better muscle function in the oldest old: Results from the Mugello Study. Eur J Intern Med. 2017;41: 39-43.
48. Macchi C, Molino-Lova R, Polcaro P, et al. Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons. Mech Ageing Dev. 2008;129: 522-527.
49. Lee J, Hong YS, Park SH, Kang KY. High serum uric acid level is associated with greater handgrip strength in the aged population. Arthritis Res Ther. 2019;21: 73.
50. Beavers KM, Beavers DP, Serra MC, Bowden RG, Wilson RL. Low relative skeletal muscle mass indicative of sarcopenia is associated with elevations in serum uric acid levels: findings from NHANES III. J Nutr Health Aging. 2009;13: 177-182.
51. Garcia-Esquinas E, Rodriguez-Artalejo F. Association between serum uric acid concentrations and grip strength: Is there effect modification by age? Clin Nutr. 2018;37: 566-572.
52. Thapaliya S, Runkana A, McMullen MR, et al. Alcohol-induced autophagy contributes to loss in skeletal muscle mass. Autophagy. 2014;10: 677-690.
53. Thomas DR. Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr. 2007;26: 389-399.
54. Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Alcohol consumption as a risk factor for sarcopenia - a meta-analysis. BMC Geriatr. 2016;16: 99.
55. Rom O, Kaisari S, Aizenbud D, Reznick AZ. Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown. Ann N Y Acad Sci. 2012;1259: 47-53.
56. Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Relation between cigarette smoking and sarcopenia: meta-analysis. Physiol Res. 2015;64: 419-426.
57. Rodriguez-Rejon AI, Ruiz-Lopez MD, Wanden-Berghe C, Artacho R. Prevalence and Diagnosis of Sarcopenia in Residential Facilities: A Systematic Review. Adv Nutr. 2019;10: 51-58.
58. Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ, 3rd. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci. 2005;60: 213-216.
59. Rolland Y, Lauwers-Cances V, Cristini C, et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr. 2009;89: 1895-1900.
60. Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Gerontol A Biol Sci Med Sci. 2012;67: 48-55.
61. Domiciano DS, Figueiredo CP, Lopes JB, et al. Discriminating sarcopenia in community-dwelling older women with high frequency of overweight/obesity: the Sao Paulo Ageing Health Study (SPAH). Osteoporos Int. 2013;24: 595-603.
62. Kim SH, Kim TH, Hwang HJ. The relationship of physical activity (PA) and walking with sarcopenia in Korean males aged 60 years and older using the Fourth Korean National Health and Nutrition Examination Survey (KNHANES IV-2, 3), 2008-2009. Arch Gerontol Geriatr. 2013;56: 472-477.
63. Akune T, Muraki S, Oka H, et al. Exercise habits during middle age are associated with lower prevalence of sarcopenia: the ROAD study. Osteoporos Int. 2014;25: 1081-1088.
64. Figueiredo CP, Domiciano DS, Lopes JB, et al. Prevalence of sarcopenia and associated risk factors by two diagnostic criteria in community-dwelling older men: the Sao Paulo Ageing Health Study (SPAH). Osteoporos Int. 2014;25: 589-596.
65. Senior HE, Henwood TR, Beller EM, Mitchell GK, Keogh JW. Prevalence and risk factors of sarcopenia among adults living in nursing homes. Maturitas. 2015;82: 418-423.
66. Martinez BP, Batista AK, Gomes IB, Olivieri FM, Camelier FW, Camelier AA. Frequency of sarcopenia and associated factors among hospitalized elderly patients. BMC Musculoskelet Disord. 2015;16: 108.
67. Aggio DA, Sartini C, Papacosta O, et al. Cross-sectional associations of objectively measured physical activity and sedentary time with sarcopenia and sarcopenic obesity in older men. Prev Med. 2016;91: 264-272.
68. Tyrovolas S, Koyanagi A, Olaya B, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a multi-continent study. Journal of Cachexia, Sarcopenia and Muscle. 2016: 312-321.
69. da Silva AP, Matos A, Ribeiro R, et al. Sarcopenia and osteoporosis in Portuguese centenarians. Eur J Clin Nutr. 2017;71: 56-63.
70. Tramontano A, Veronese N, Sergi G, et al. Prevalence of sarcopenia and associated factors in the healthy older adults of the Peruvian Andes. Arch Gerontol Geriatr. 2017;68: 49-54.
71. Hai S, Wang H, Cao L, et al. Association between sarcopenia with lifestyle and family function among community-dwelling Chinese aged 60 years and older. BMC Geriatr. 2017;17: 187.
72. Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc. 2013;14: 170-178.
73. Wang H, Hai S, Cao L, Zhou J, Liu P, Dong BR. Estimation of prevalence of sarcopenia by using a new bioelectrical impedance analysis in Chinese community-dwelling elderly people. BMC Geriatr. 2016;16: 216.
74. Emma Patterson, Guidelines for Data Processing and Analysis of the International PhysicalActivity. Questionnaire (IPAQ)– Short and Long Forms, 2005 Nov
75. Auyeung TW, Arai H, Chen LK, Woo J. Letter to the editor: Normative data of handgrip strength in 26344 older adults - a pooled dataset from eight cohorts in Asia. J Nutr Health Aging. 2020;24: 125-126.
76. Kim TN, Park MS, Yang SJ, et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33: 1497-1499.
77. Veronese N, Pizzol D, Demurtas J, et al. Association between sarcopenia and diabetes: a systematic review and meta-analysis of observational studies. European Geriatric Medicine. 2019;10: 685-696.
78. Flicker L, McCaul KA, Hankey GJ, et al. Body mass index and survival in men and women aged 70 to 75. J Am Geriatr Soc. 2010;58: 234-241.
79. Reijnierse EM, Trappenburg MC, Leter MJ, et al. Serum albumin and muscle measures in a cohort of healthy young and old participants. Age (Dordr). 2015;37: 88.
80. Group EUCCS, Regitz-Zagrosek V, Oertelt-Prigione S, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37: 24-34.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/62949-
dc.description.abstract前言:肌少症描述伴隨老化的肌肉量下降加上肌力減退或身體表現變差。肌少症的後果包含跌倒、骨折、失能、住院或需入住長照機構、生活品質下降,甚至死亡。肌少症的定義和診斷尚未一致,亞洲肌少症小組(AWGS)在2014年提出肌力減退或身體表現變差此二項至少一項加上肌肉量下降以診斷肌少症。肌少症的原因包括老化、疾病、營養失調、缺乏活動等,身體活動是預防肌少症的一個重要關鍵。國際身體活動量調查問卷-短版(IPAQ-S)是測量身體活動量的問卷之一,臺灣版本的IPAQ-S信度及效度都已經過檢定。本研究的主要目的為以臺灣版本的IPAQ-S和亞洲定義的肌少症去探討老年人身體活動量和肌少症的相關性,次要目的為探討其他和肌少症相關之因子。
材料及方法:本研究為橫斷式研究,搜集一次性問卷、老人健檢和身體量測的數據。研究族群為65歲以上於2019年參與某區域醫院老人健檢的志願者,本研究通過院方的研究倫理審查,所有受試者皆簽署知情同意。
結果:最終納入分析的有500位參與者,平均年紀為73.87 歲,265位(53%)為女性。106位(21.2%)被歸類為低度身體活動量,394位(78.8%)為中至高度身體活動量。大多數女性參與者(142/265, 53.5%)及男性參與者(131/235, 55.7%)為中度身體活動量。依照2014年AWGS診斷標準,共有104位(20.8%)參與者符合肌少症診斷,其中女性67位,男性37位。女性參與者在調整年齡、身體質量指數、白蛋白、三酸甘油酯、血紅素後,相對於低度身體活動量組,中至高度身體活動量對肌少症的勝算比為0.47(95%信賴區間 0.24-0.90, p值=0.024)。男性參與者在調整年齡、身體質量指數、血紅素、飲酒、心血管疾病史、糖尿病史、高血壓病史、機構居住、總膽固醇、空腹血糖、低密度脂蛋白膽固醇、高密度脂蛋白膽固醇、三酸甘油酯後,相對於低度身體活動量組,中至高度身體活動量對肌少症的勝算比為0.18(95%信賴區間 0.05-0.59, p值=0.005)。依照2019年AWGS診斷標準,共有138位(27.6%)參與者符合肌少症診斷,其中女性87位,男性51位。女性參與者在調整年齡、身體質量指數、白蛋白、血紅素後,相對於低度身體活動量組,中至高度身體活動量對肌少症的勝算比為0.52(95%信賴區間 0.27-0.98, p值=0.043)。男性參與者在調整年齡、身體質量指數、心血管疾病史、心臟病史、機構居住後,相對於低度身體活動量組,中至高度身體活動量對肌少症的勝算比為0.34(95%信賴區間 0.12-0.95, p值=0.039)。
結論: 不論依照2014或2019年AWGS的肌少症診斷標準,在調整干擾因子後,身體活動量對肌少症有統計上顯著的保護作用,且在男性參與者較為明顯,較高的身體質量指數對肌少症有保護作用,老化則為肌少症之危險因子。依照2014年AWGS的肌少症診斷標準,其餘呈現統計上顯著相關者還有:較高濃度的白蛋白在女性參與者對肌少症有保護作用、糖尿病史在男性參與者對肌少症有保護作用、心血管疾病史則為男性參與者肌少症之危險因子。
zh_TW
dc.description.abstractIntroduction: Sarcopenia is characterized by age-related lean muscle mass decline and low muscle strength and/or performance. The consequences of sarcopenia are falls, fracture, disability, hospital admission or need for long-term care placement, poorer quality of life, and even mortality. The definition and diagnosis of sarcopenia remains inconsistent. In 2014, Asian Working Group for Sarcopenia (AWGS) recommended using low muscle mass plus low muscle strength and/or low physical performance to diagnose sarcopenia. The causes of sarcopenia are multifactorial, such as aging, disease, malnutrition, and inactivity, etc. Physical activity (PA) is one of the keys to preventing sarcopenia. The international physical activity questionnaire-short version (IPAQ-S) was one of questionnaires used to measure PA. The validity and reliability of the Taiwan version of IPAQ-S has been verified. In this study, our primary aim is to use the Taiwan version of IPAQ-S and the AWGS definition of sarcopenia to examine the relationship between PA and the presence of sarcopenia in older adults. Our secondary aim is to identify other associated factors of sarcopenia.
Materials and methods: We designed a cross-sectional study, and questionnaires and physical examinations were used to collect information once. We recruited volunteers from those aged ≧65 years old attending an older adults’ health exam at a regional hospital in 2019. The study had been approved by the Institutional Review Board (IRB) of the regional hospital (TCHIRB-10801017) and all the participants provided written informed consent.
Results: Data from 500 participants were used for the analysis. The study participants had a mean age of 73.87 years old, with 47% men and 53% women. Of the 500 participants, 106 (21.2%) participants were classified as low PA, and 394 were classified as moderate to high PA (78.8%) groups. For both genders, most female (142/265, 53.5%) and male (131/235, 55.7%) participants’ PA levels were moderate. According to the 2014 AWGS diagnostic criteria of sarcopenia, a total of 104 (20.8%) participants were classified as having sarcopenia, among whom 67 were women and 37 were men. Compared with the low PA group, for the female participants, the overall odds ratio (OR) of moderate to high PA to sarcopenia was 0.47 (95% CI: 0.24-0.90, p-value=0.024), after adjusting for age, body mass index (BMI), and albumin, triglyceride and hemoglobin levels. As for the male participants, compared with the low PA group, the overall odds ratio (OR) of moderate to high PA to sarcopenia was 0.18 (95% CI: 0.05-0.59, p-value=0.005), after adjusting for age, body mass index (BMI), alcohol drinking, history of cardiovascular disease, history of diabetes mellitus, history of hypertension, institutionalization, and hemoglobin, total cholesterol, FPG, LDL-C, HDL-C, and triglyceride levels. According to the 2019 AWGS definition of sarcopenia, a total of 138 (27.6%) participants were classified as having sarcopenia, among whom 87 were women and 51 were men. Compared with the low PA group, for the female participants, the overall odds ratio (OR) of moderate to high PA to sarcopenia was 0.52 (95% CI: 0.27-0.98, p-value=0.043), after adjusting for age, body mass index (BMI), and albumin and hemoglobin levels. As for the male participants, compared with the low PA group, the overall odds ratio (OR) of moderate to high PA to sarcopenia was 0.34 (95% CI: 0.12-0.95, p-value=0.039), after adjusting for age, body mass index (BMI), history of cardiovascular disease, history of heart disease and institutionalization.
Conclusion: Regardless of whether the 2014 or the 2019 AWGS diagnostic criteria of sarcopenia was applied, a significant protective effect of physical activity on sarcopenia was found among the older adults after adjusting for confounders, especially for the male participants. Higher BMI showed protective effect on sarcopenia, while aging was a risk factor of sarcopenia. According to the 2014 AWGS diagnostic criteria of sarcopenia, a higher albumin level showed a protective effect on sarcopenia for the female participants, while a history of diabetes mellitus showed a protective effect and a history of cardiovascular disease was a risk factor of sarcopenia for the male participants.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T16:16:06Z (GMT). No. of bitstreams: 1
ntu-109-R07849038-1.pdf: 2385070 bytes, checksum: 04b3a7cc130843b8c8f8e8b7b01281cb (MD5)
Previous issue date: 2020
en
dc.description.tableofcontentsTable of Contents
Verification letter from the oral examination committee………...…………...…………...………... i
Acknowledgements…………………………………………………………………. ………………ii
Abbreviations…………….…………………....………………………………………………….... iii
Chinese abstract……………………………………………………………………….………..........iv
English abstract………………………………………………………………………….………......vi
Table of contents………………………………………………………………..…………….....…. ix
List of figures………………………………………………………………………………………. xi
List of tables………………………………………………………………………………………...xii
Chapter 1. Introduction……….…………………………………….………………….........……….1
1.1 Sarcopenia………………………………………………………………………………......1
1.2 Physical activity………………………………………………………………………….….2
Chapter 2. Literature review………………………………………………….....................................5
2. 1 The relationship between physical activity and the presence of sarcopenia in older
adults………………………………………..... …………………………………..... ……… 5
2.2 Other factors affecting sarcopenia…………………………………………………………. 5
2.2.1 Aging…………………..…………………………………………………………...…5
2.2.2 Body mass index………………….…………………….…………………………….5
2.2.3 Gender……………………….……………………………….……………………….6
2.2.4 Education level………………….…………………….………………………………6
2.2.5 Albumin ………………….…………………….…………………………….……….6
2.2.6 Insulin resistance ……………….…………………….………………...…………….6
2.2.7 Lipid profiles ……………….…………………….……………………….………….7
2.2.8 Hemoglobin……………….…………………….…………………………………….7
2.2.9 Uric acid……………….…………………….……………………………….……….7
2.2.10 Alcohol drinking……………….…………………….…………..………………….8
2.2.11 Smoking ……………….…………………….………….…………………….…….8
2.2.12 Institutionalization..........................…….…….…………….………...………….......8
2.3 Gaps and aims of this study…………………………….………………..………………….8
Chapter 3. Materials and methods………………………….……………………………………….14
3.1 Study population……………………….………………………….……………………….14
3.2 Measurements……………………….…………………………….……………………….14
3.2.1 Assessment of sarcopenia………….…………………..…………………………….14
3.2.2. Assessment of physical activity…………………………………..…………………15
3.3 Measurement of demographic factors, clinical factors and comorbidities…..……….....…16
3.4 Statistical analyses………………………………..……………………………..…………17
Chapter 4. Results………………………………..……………………………………………….…19
4.1 Demographic characteristics of the study participants………………….…………………19
4.2 Physical activity and sarcopenia…………….…………………………..…………………19
4.3 Other associated factors of sarcopenia ………............................…………………………20
Chapter 5. Discussion….……………….……….……………………………..……………………31
5.1 Main findings.……………….………….…..………………………..……………………31
5.2 Comparison with previous studies….……………….......…………..……….……………32
5.3 Biological mechanism…………………..………………….……….……............……..…33
5.4 Clinical care and public health implication.........................................................................34
5.5 Strengths and study limitations...........................................................................................35
Chapter 6. Conclusions…………………..………………….…………………………….……..…40
References………………………………………………….....………………….…………………41
Appendices……………………………………………………………………………………….....50
dc.language.isoen
dc.subject肌少症zh_TW
dc.subject身體活動zh_TW
dc.subject老年人zh_TW
dc.subject國際身體活動量調查問卷zh_TW
dc.subject亞洲肌少症工作小組zh_TW
dc.subjectIPAQen
dc.subjectphysical activityen
dc.subjectolder adultsen
dc.subjectsarcopeniaen
dc.subjectAWGSen
dc.title老年人身體活動量與肌少症的相關性zh_TW
dc.titleThe Relationship Between Physical Activity and the Presence of Sarcopenia in Older Adultsen
dc.typeThesis
dc.date.schoolyear108-2
dc.description.degree碩士
dc.contributor.oralexamcommittee劉仁沛(Jen-Pei Liu),程蘊菁(Yen-Ching Chen),吳岱穎(Tai-Yin Wu)
dc.subject.keyword肌少症,身體活動,老年人,國際身體活動量調查問卷,亞洲肌少症工作小組,zh_TW
dc.subject.keywordsarcopenia,physical activity,older adults,IPAQ,AWGS,en
dc.relation.page58
dc.identifier.doi10.6342/NTU202000862
dc.rights.note有償授權
dc.date.accepted2020-05-26
dc.contributor.author-college公共衛生學院zh_TW
dc.contributor.author-dept流行病學與預防醫學研究所zh_TW
顯示於系所單位:流行病學與預防醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-109-1.pdf
  未授權公開取用
2.33 MBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved